Depressive comorbidity in type 2 Diabetes: Prevalence and associated factors
DOI:
https://doi.org/10.62438/tunismed.v104i01.5434Keywords:
Type 2 diabetes, Depression, Blood glucose control, Quality of life, Self-esteem, Treatment satisfactionAbstract
Background: The comorbidity diabetes depression is frequent and would have a synergistic effect. Depression is underdiagnosed in diabetology consultations.
Methods: This was a cross-sectional study that included 102 outpatients with type 2 Diabetes mellitus (T2DM) recruited during April and May 2019. A pre-established form was filled out from the interview of the patients and the medical file review. Depression, Therapeutic adherence, self-esteem, temperament, satisfaction of treatment, quality of life and physical activity were assessed by validated questionnaires.
Results: The average age of the patients was 53.4± 8.5 years, sex-ratio was 0.7. 76.5% have exhibited depressive symptoms; 51% of the patients have had moderate to severe depression. Depression was associated with female gender (p=0.04) and psychiatric family history (p=0.01). Patients with depression have had significantly higher HbA1c levels (p=0.05) and significantly lower HDL-C levels (p=0.05). Regarding psychosocial factors, depression was associated with low self-esteem (p= 0.005) and significantly higher scores of depressive (p=0.002) and cyclothymic (p=0.003) temperaments. Depression was also associated with significantly lower treatment satisfaction (p=0.01) and poor quality of life. In multivariate study, factors independently associated with depression were female gender, low HDL-C, quality of life score without diabetes and low self-esteem score.
Conclusion: This study showed, despite limitations, that depression is frequent in patients with T2DM and was associated with several sociodemographic, anamnestic, clinical and psychological characteristics.
Downloads
References
https://www.who.int/fr/news-room/fact-sheets/detail/diabetes [Internet]. [cited 2022 Jan 23]. Available from: https://www.who.int/fr/news-room/fact-sheets/detail/diabetes
https://www.who.int/fr/news-room/fact-sheets/detail/depression [Internet]. [cited 2022 Mar 10]. Available from: https://www.who.int/fr/news-room/fact-sheets/detail/depression
Sebbani M, Dali Sahi M, Amine M, Aouar A. Prévalence du diabète de type 2 et facteurs associés au cours de la dépression. L’Encéphale. 2014 Feb 1;40(1):9–14.
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006 Nov;23(11):1165–73.
de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001 Aug;63(4):619–30.
Katon W, Fan MY, Unützer J, Taylor J, Pincus H, Schoenbaum M. Depression and diabetes: a potentially lethal combination. J Gen Intern Med. 2008 Oct;23(10):1571–5.
American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2020 Dec 4;44(Supplement_1):S73–84.
American Diabetes Association. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2020 Dec 4;44(Supplement_1):S125–50.
Beck AT, Rial WY, Rickels K. Short Form of Depression Inventory: Cross-Validation. Psychol Rep. 1974 Jun 1;34(3_suppl):1184–6.
Rosenberg M. Society and the Adolescent Self-Image. Princeton University Press; 2015. 339 p.
Akiskal HS, Mendlowicz MV, Jean-Louis G, Rapaport MH, Kelsoe JR, Gillin JC, et al. TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J Affect Disord. 2005 Mar;85(1–2):45–52.
Ostini R, Dower J, Donald M. The Audit of Diabetes-Dependent Quality of Life 19 (ADDQoL): feasibility, reliability and validity in a population-based sample of Australian adults. Qual Life Res. 2012 Oct;21(8):1471–7.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008 May;10(5):348–54.
Wilbur K. Diabetes Treatment Satisfaction Questionnaire - an Arabic adaptation for Qatar. Diabetes Res Clin Pract. 2013 Feb;99(2):e24-26.
Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381–95.
Kulzer B, Priesterroth L. [Depressive disorders: An often underestimated comorbidity in diabetes]. Dtsch Med Wochenschr. 2020 Nov;145(22):1614–23.
Roy T, Lloyd CE. Epidemiology of depression and diabetes: A systematic review. Journal of Affective Disorders. 2012 Oct;142:S8–21.
Wang F, Wang S, Zong QQ, Zhang Q, Ng CH, Ungvari GS, et al. Prevalence of comorbid major depressive disorder in Type 2 diabetes: a meta-analysis of comparative and epidemiological studies. Diabet Med. 2019 Aug;36(8):961–9.
Lloyd CE, Nouwen A, Sartorius N, Ahmed HU, Alvarez A, Bahendeka S, et al. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET-DD) study, a collaborative study carried out in 14 countries. Diabet Med. 2018 Jun;35(6):760–9.
Brown LC, Majumdar SR, Newman SC, Johnson JA. Type 2 diabetes does not increase risk of depression. CMAJ. 2006 Jul 4;175(1):42–6.
Paddison C a. M, Eborall HC, French DP, Kinmonth AL, Prevost AT, Griffin SJ, et al. Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial. Br J Health Psychol. 2011 Feb;16(Pt 1):213–26.
Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010 Dec;53(12):2480–6.
Icks A, Wittgens C, Haastert B, Jöckel KH, Engel M, Erbel R, et al. High Depressive Symptoms in Previously Undetected Diabetes - 10-Year Follow-Up Results of the Heinz Nixdorf Recall Study. Clin Epidemiol. 2021;13:429–38.
Aschner P, Gagliardino JJ, Ilkova H, Lavalle F, Ramachandran A, Mbanya JC, et al. High Prevalence of Depressive Symptoms in Patients With Type 1 and Type 2 Diabetes in Developing Countries: Results From the International Diabetes Management Practices Study. Diabetes Care. 2021 May;44(5):1100–7.
Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and Type 2 Diabetes Over the Lifespan: A meta-analysis. Diabetes Care. 2008 Dec 1;31(12):2383–90.
Pan A, Sun Q, Okereke OI, Rexrode KM, Rubin RR, Lucas M, et al. Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia. 2012 Jan;55(1):63–72.
Alajmani DSA, Alkaabi AM, Alhosani MW, Folad AA, Abdouli FA, Carrick FR, et al. Prevalence of Undiagnosed Depression in Patients With Type 2 Diabetes. Front Endocrinol (Lausanne). 2019;10:259.
Kav S, Yilmaz AA, Bulut Y, Dogan N. Self-efficacy, depression and self-care activities of people with type 2 diabetes in Turkey. Collegian. 2017;24(1):27–35.
Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000 Jul;23(7):934–42.
Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009 Feb;26(2):153–61.
Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes. Diabet Med. 2008 Sep;25(9):1096–101.
Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008 Jun 18;299(23):2751–9.
Lin EHB, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010 Feb;33(2):264–9.
Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care. 2005 Jun;28(6):1339–45.
Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005 Apr 1;161(7):652–60.
Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BWJH, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry. 2010 Mar;67(3):220–9.
Messaoud A, Mensi R, Mhalla A, Hallara I, Neffati F, Douki W, et al. [Dyslipidemia and suicidal risk in patients with psychiatric disorders]. Encephale. 2018 Sep;44(4):315–20.
Mhalla A, Bel Hadj Salah W, Mensi R, Amamou B, Messaoud A, Gassab L, et al. Lipid profile in schizophrenia: case control study. Tunis Med. 2018 Jan;96(1):22–9.
Skilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry. 2007 Dec 1;62(11):1251–7.
Messaoud A, Mensi R, Mrad A, Mhalla A, Azizi I, Amemou B, et al. Is low total cholesterol levels associated with suicide attempt in depressive patients? Ann Gen Psychiatry. 2017;16:20.
Walker AJ, Kim Y, Borissiouk I, Rehder R, Dodd S, Morris G, et al. Statins: Neurobiological underpinnings and mechanisms in mood disorders. Neurosci Biobehav Rev. 2021 Sep;128:693–708.
Anderson BJ, Edelstein S, Abramson NW, Katz LEL, Yasuda PM, Lavietes SJ, et al. Depressive symptoms and quality of life in adolescents with type 2 diabetes: baseline data from the TODAY study. Diabetes Care. 2011 Oct;34(10):2205–7.
Egede LE, Hernández-Tejada MA. Effect of comorbid depression on quality of life in adults with Type 2 diabetes. Expert Rev Pharmacoecon Outcomes Res. 2013 Feb;13(1):83–91.
Hernandez R, Ruggiero L, Prohaska TR, Chavez N, Boughton SW, Peacock N, et al. A Cross-sectional Study of Depressive Symptoms and Diabetes Self-care in African Americans and Hispanics/Latinos With Diabetes: The Role of Self-efficacy. Diabetes Educ. 2016 Aug;42(4):452–61.
Rivera-Hernandez M. Depression, self-esteem, diabetes care and self-care behaviors among middle-aged and older Mexicans. Diabetes Res Clin Pract. 2014 Jul;105(1):70–8.
Jalali N, Taghavi Kojidi H, Badrfam R, Zandifar A. The relationship between personality disorder, depression and eating disorder with treatment adherence in patients with type 2 diabetes; a cross-sectional study in diabetic patients in Iran. J Diabetes Metab Disord. 2021 Jun;20(1):153–9.
Świątoniowska-Lonc N, Tański W, Polański J, Jankowska-Polańska B, Mazur G. Psychosocial Determinants of Treatment Adherence in Patients with Type 2 Diabetes - A Review. Diabetes Metab Syndr Obes. 2021;14:2701–15.
Zhang Y, Ting RZ, Yang W, Jia W, Li W, Ji L, et al. Depression in Chinese patients with type 2 diabetes: associations with hyperglycemia, hypoglycemia, and poor treatment adherence. J Diabetes. 2015 Nov;7(6):800–8.
Kendler KS, Gatz M, Gardner CO, Pedersen NL. Personality and major depression: a Swedish longitudinal, population-based twin study. Arch Gen Psychiatry. 2006 Oct;63(10):1113–20.
Zobel A, Barkow K, Schulze-Rauschenbach S, Von Widdern O, Metten M, Pfeiffer U, et al. High neuroticism and depressive temperament are associated with dysfunctional regulation of the hypothalamic-pituitary-adrenocortical system in healthy volunteers. Acta Psychiatr Scand. 2004 May;109(5):392–9.
Additional Files
Published
Issue
Section
License
Copyright (c) 2026 La Tunisie Médicale
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
